Skip to Content
Merck

Lymphatics in bone arise from pre-existing lymphatics.

Development (Cambridge, England) (2020-03-20)
Marco Monroy, Anna L McCarter, Devon Hominick, Nina Cassidy, Michael T Dellinger
ABSTRACT

Bones do not normally have lymphatics. However, individuals with generalized lymphatic anomaly (GLA) or Gorham-Stout disease (GSD) develop ectopic lymphatics in bone. Despite growing interest in the development of tissue-specific lymphatics, the cellular origin of bone lymphatic endothelial cells (bLECs) is not known and the development of bone lymphatics has not been fully characterized. Here, we describe the development of bone lymphatics in mouse models of GLA and GSD. Through lineage-tracing experiments, we show that bLECs arise from pre-existing Prox1-positive LECs. We show that bone lymphatics develop in a stepwise manner where regional lymphatics grow, breach the periosteum and then invade bone. We also show that the development of bone lymphatics is impaired in mice that lack osteoclasts. Last, we show that rapamycin can suppress the growth of bone lymphatics in our models of GLA and GSD. In summary, we show that bLECs can arise from pre-existing LECs and that rapamycin can prevent the growth of bone lymphatics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Doxycycline hyclate
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 200
Sigma-Aldrich
TWEEN® 80, suitable for cell culture, suitable for insect cell culture, viscous liquid
Sigma-Aldrich
Tamoxifen, ≥99%
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, for molecular biology